| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 05/14/2009 | WO2009061761A2 Fungicidal heterocyclic amines |
| 05/14/2009 | WO2009061652A1 Compounds which modulate the cb2 receptor |
| 05/14/2009 | WO2009060742A1 Organic electroluminescent device, display device, and illuminating device |
| 05/14/2009 | WO2009060054A1 Triazole derivatives as scd inhibitors |
| 05/14/2009 | WO2009060053A1 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors |
| 05/14/2009 | WO2009059943A1 4-benzylamino-1-carboxyacyl-piperidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis |
| 05/14/2009 | WO2008137816A3 Tricyclic compounds as matrix metalloproteinase inhibitors |
| 05/14/2009 | WO2008118823A3 Compositions and methods for inhibition of the jak pathway |
| 05/14/2009 | US20090124668 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/14/2009 | US20090124666 Trpv1 antagonists |
| 05/14/2009 | US20090124665 Potassium Channel Inhibitors |
| 05/14/2009 | US20090124629 3-(1,2,4-triazol-3ylalkyl) azabriclo (3.1.0) hexane derivatives as modulators of dopamine d3 receptors |
| 05/14/2009 | US20090124625 Novel alkynyl derivatives as modulators of metatropic glutamate receptors |
| 05/14/2009 | US20090124621 Pyrazole derivatives as kinase inhibitors |
| 05/14/2009 | US20090124620 Plasminogen activator inhibitor-1 inhibitor |
| 05/14/2009 | US20090124618 2-morpholino-4-pyrimidone compound |
| 05/14/2009 | US20090124617 Quinolone derivative or salt thereof |
| 05/14/2009 | US20090124616 7-nonsubstituted indole mcl-1 inhibitors |
| 05/14/2009 | US20090124615 3-[((1R)-1-{2-Chloro-3-[(1-methyl-4-piperidinyl)oxy]phenyl}ethyl)oxy]-5-[5-(1-methyl-1H-pyrazol-4-yl)-1H-benzimidazol-1-yl]-2-thiophenecarboxamide; polo like kinase enzyme inhibitors; anticarcinogenic agents for treating cancer |
| 05/14/2009 | US20090124613 Substituted Heterocyclic Ethers and Their Use in CNS Disorders |
| 05/14/2009 | US20090124610 Pharmaceutical compounds |
| 05/14/2009 | US20090124609 Fused heterocyclic derivatives and methods of use |
| 05/14/2009 | US20090124608 CB2 Receptor Modulators In Neurodegenerative Diseases And Applications Of The Same |
| 05/14/2009 | US20090124605 Pyrazolo-Quinazoline Derivatives, Process for Their Preparation and Their Use as Kinase Inhibitors |
| 05/14/2009 | US20090124604 4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine diseases |
| 05/14/2009 | US20090124598 Pharmaceutical use of substituted amides |
| 05/14/2009 | US20090124580 Autoimmune diseases; water solubility of prodrug can be tailored to improve bioavailability using substution at amine groups; inhibitors of degranulation of immune cells; inhibit/activate Fc receptor signaling cascades |
| 05/14/2009 | US20090123373 Amyloid-imaging agents |
| 05/14/2009 | US20090123372 radioactively labeled high affinity CA-IX ligands that identify enzymatic activity of cell-surface expressed carbonic anhydrase-IX (CA-IX), a protein over expressed in patients in with tumor growth; sulfonamide compounds useful for in vivo positron emission tomography for the diagnosis of cancer |
| 05/14/2009 | CA2705113A1 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors |
| 05/14/2009 | CA2704684A1 Compounds which modulate the cb2 receptor |
| 05/14/2009 | CA2704633A1 4-benzylamino-1-carboxyacyl-piperidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis |
| 05/13/2009 | EP2058305A1 Urea derivative |
| 05/13/2009 | EP2057153A1 (3-aryl-piperazin-1-yl), (2-aryl-morpholin-4-yl) and (2-aryl- thiomorpholin-4-yl) derivatives of 6,7-dialkoxyquinazoline, 6,7- dialkoxyphtalazine and 6,7-dialkoxyisoquinoline |
| 05/13/2009 | EP2057152A1 Single enantiomer beta-agonists, methods for the production thereof and the use thereof as medication |
| 05/13/2009 | EP2057151A2 Process for purification of aprepitant |
| 05/13/2009 | EP2057147A1 Pyrimidine derivatives |
| 05/13/2009 | EP2057143A2 5-substituted isoindoline compounds |
| 05/13/2009 | EP2057141A1 Pyrimidone compounds as gsk-3 inhibitors |
| 05/13/2009 | EP2057140A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| 05/13/2009 | EP2057138A1 Novel chromene and thiochromene carboxamide derivatives, methods for preparing same and therapeutic applications of same |
| 05/13/2009 | EP2057133A2 Di-amino-substituted heterocyclic compounds and methods of use |
| 05/13/2009 | EP2057124A2 Compounds and compositions as itpkb inhibitors |
| 05/13/2009 | EP1912957A4 Ep4 receptor agonist, compositions and methods thereof |
| 05/13/2009 | EP1549624B1 Inhibitors of fatty acid amide hydrolase |
| 05/13/2009 | EP1252140B1 Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 05/13/2009 | EP0934311B1 New heterocyclylmethyl-substituted pyrazol derivates |
| 05/13/2009 | CN101432281A 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling |
| 05/13/2009 | CN101432276A Quinoline derivatives |
| 05/13/2009 | CN101429170A Biaryl heterocyclic compounds and methods of making and using the same |
| 05/13/2009 | CN100486976C Fluorescent molecular probe and use for inspecting transient metal and heavy metal ion |
| 05/13/2009 | CN100486969C Cis-2,4,5-triphenyl-imidazoline and its application in tumor treatment |
| 05/13/2009 | CN100486576C Substituted pyridinones as modulators of P38MAP kinase |
| 05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
| 05/12/2009 | US7531661 Such as N-methyl(1-{2-[(1R,5S)-3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-2,3-dihydro-1H-inden-1-yl)methanamine; chemokine receptor antagonists; prevention or treatment of a human T-cell leukemia/lymphoma virus infection |
| 05/12/2009 | US7531564 Substituted benzoxazoles as estrogenic agents |
| 05/12/2009 | US7531559 Fungicidal 1,2,3 triazole derivatives |
| 05/12/2009 | US7531557 oral bioavailablility, oral administration; inhibition of orexigenic effects; side effects reduction; alcoholism; 6-(2-Fluoro-4-{[2-(tetrahydro-pyran-4-yl)-ethylamino]-methyl}-phenoxy)-nicotinamide |
| 05/12/2009 | US7531556 Compositions useful as inhibitors of rock and other protein kinases |
| 05/12/2009 | US7531553 Heterocyclic compounds and methods of use |
| 05/12/2009 | US7531549 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 05/12/2009 | US7531548 to inhibit the replication of mutant strains, in particular strains which are resistant to NNRTI drugs (Non Nucleoside Reverse Transcriptase Inhibitor drugs); to treat HIV infections |
| 05/12/2009 | US7531542 Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor |
| 05/12/2009 | US7531537 Benzofuran derivative |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531535 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 05/12/2009 | US7531532 Pyridine derivative and pyrimidine derivative |
| 05/12/2009 | CA2428604C Microbiocidal n-phenyl-n-[4-(4-pyridyl-2-pyrimidin-2-yl]-amine derivatives |
| 05/12/2009 | CA2361402C Bis-sulfonamides |
| 05/12/2009 | CA2278553C Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulators |
| 05/12/2009 | CA2264005C Piperazino derivatives as neurokinin antagonists |
| 05/07/2009 | WO2009058348A1 Amide derivatives as sirtuin modulators |
| 05/07/2009 | WO2009058300A1 Biphenyl derivatives as modulators of the histamine-h3 receptor useful for the treatment of disorders related thereto |
| 05/07/2009 | WO2009058267A2 Benzomorpholine derivatives and methods of use |
| 05/07/2009 | WO2009058051A1 5-substituted indol-3-carboxylic acid derivatives exhibiting antiviral activity a method for the production and use thereof |
| 05/07/2009 | WO2009057827A1 Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors |
| 05/07/2009 | WO2009057784A1 Heterocyclic compound |
| 05/07/2009 | WO2009056693A1 Novel derivatives of n, n'- 2, 4-dianilinopyrimidines, preparation thereof as medicaments pharmaceutical compositions and in particular as ikk inhibitors |
| 05/07/2009 | WO2009056617A2 4,4-disubstituted piperdines as renin inhibitors |
| 05/07/2009 | WO2009055917A1 Inhibitors of histone deacetylase |
| 05/07/2009 | WO2009025983A3 Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives |
| 05/07/2009 | WO2009009002A3 Hydrogen chloride salt of a substituted 5-oxazol-2-yl-quinoline compound and a process for the production thereof |
| 05/07/2009 | WO2009006389A3 Pyrimidine derivatives useful as raf kinase inhibitors |
| 05/07/2009 | WO2008153792A3 Gamma secretase modulators |
| 05/07/2009 | US20090118506 6,11-bridged biaryl macrolides |
| 05/07/2009 | US20090118503 Faah inhibitors |
| 05/07/2009 | US20090118502 organic or inorganic salt of N-{3-[4'-(4-Aminomethyl-[1,2,3]triazol-1-ylmethyl)-2-fluoro-biphenyl- 4-yl]-2-oxo-oxazolidin-5-(S)-ylmethyl}-acetamide; anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents |
| 05/07/2009 | US20090118501 enzyme inhibitor for treating diabetes; 1-(4-Methyl-cyclohexyl)-3-(5-methyl-thiazol-2-yl)-1-(4-oxo-cyclohexyl)-urea |
| 05/07/2009 | US20090118307 Aryl Sulfonamides |
| 05/07/2009 | US20090118305 Pyridine and pyrazine derivatives - 083 |
| 05/07/2009 | US20090118288 N-Benzyl-Morpholine Derivatives as Modulators of the Chemokine Receptor |
| 05/07/2009 | US20090118287 Organic compounds |
| 05/07/2009 | US20090118284 Novel compounds that are ERK inhibitors |
| 05/07/2009 | US20090118283 Amide Derivatives as Kinase Inhibitors |
| 05/07/2009 | US20090118282 Compounds and methods for treatment of amyloid-beta-peptide related disorders |
| 05/07/2009 | US20090118281 Amino Alcohol Derivatives And Their Use As Renin Inhibitor |
| 05/07/2009 | US20090118277 3 Unsubstituted N-(aryl- or heteroaryl)-pyrazolo[1,5-a]pyrimidines as Kinase Inhibitors |
| 05/07/2009 | US20090118273 Compounds and Compositions as Protein Kinase Inhibitors |
| 05/07/2009 | US20090118270 Phosphodiesterase 4 inhibitors |
| 05/07/2009 | US20090118263 Novel Adenine Compound |